Table 1: Clinical data, followup, and FUS break-apart in 14 patients with low-grade fibromyxoid sarcoma, diagnosed at the Sarcoma Centre of Aarhus University Hospital in the period of 1979 to 2010.

CaseAge/sexSizeLocationDepthTreatmentMarginRelapse time/locationRelapse treatmentFollowupFUS

18/M8PelvicSubfascialSurgeryMarginal8.0/Local, intra-abdominalSurgery, chemo- + radiotherapy24.3Neg.
238/F4HandSubfascialSurgery + radiotherapyMarginal17.5/LocalSurgery21.7Neg.
354/F3ThighSubcutaneousSurgeryWide6.0Neg.
437/F6ThighSubfascialSurgeryWide5.0Pos.
514/M5BrachiumSubfascialSurgeryMarginal4.8Neg.
637/F26GlutealSubfascialSurgeryMarginal4.1/LocalNone9.0Pos.
753/F2Neck/headSubfascialSurgeryMarginal7.7Neg.
824/F25Abdominal wallSubfascialSurgeryWide4.6Neg.
930/F3Abdominal wallSubfascialSurgeryMarginal1.9/LocalSurgery2.5Neg.
1035/M4Neck/headSubfascialSurgeryWide5.2Neg.
1164/M9GlutealSubfascialSurgeryMarginal5.0Neg.
1214/M3BrachiumSubfascialSurgeryMarginal4.0Pos.
1318/F9GlutealSubfascialChemotherapy0/Lung, liverChemotherapy3.2Neg.
1463/F3GlutealSubfascialSurgeryMarginal−0.3/Lung, brachium, and thighSurgery2.8Neg.